Compounds > 1,2,3,4-tetrahydroisoquinoline
Page last updated: 2024-08-17

1,2,3,4-tetrahydroisoquinoline and Cancer of Prostate

1,2,3,4-tetrahydroisoquinoline has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Härkönen, P; Hedblom, A; Johansson, ME; Larsson, R; Miftakhova, RR; Persson, JL; Sarwar, M; Semenas, J; Shcherbina, L; Sterner, O1
Drake, JM; Huang, J1
Amodeo, P; Arroyo, FJ; Bianchini, G; De Petrocellis, L; López-Alvarado, P; Martín, MA; Menéndez, JC; Orlando, P; Roncero, C; Sánchez, A; Schiano Moriello, A; Vitale, RM1

Other Studies

3 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Cancer of Prostate

ArticleYear
The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-02, Volume: 111, Issue:35

    Topics: Animals; Apoptosis; Cell Proliferation; Cell Survival; Diketopiperazines; Disease Models, Animal; Drug Discovery; Humans; Indoles; Isoquinolines; Male; Mice; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Tetrahydroisoquinolines; Xenograft Model Antitumor Assays

2014
PIP5K1α inhibition as a therapeutic strategy for prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-02, Volume: 111, Issue:35

    Topics: Animals; Diketopiperazines; Humans; Indoles; Isoquinolines; Male; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Tetrahydroisoquinolines

2014
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
    Journal of medicinal chemistry, 2016, 06-23, Volume: 59, Issue:12

    Topics: Animals; Antineoplastic Agents; Calcium; Cell Proliferation; Diketopiperazines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Prostatic Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines; TRPM Cation Channels; Tumor Cells, Cultured; Urea

2016